Physician profile
Otha Myles
NPI 1649379546
$61,063.46
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $10K · 2021: $7,476 · 2022: $5,821.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $31,626.08 | 2019-2022 | |
| Pfizer INC. | $17,776.99 | 2019-2022 | |
| Viiv Healthcare Company | $10,605.50 | 2019-2021 | |
| Janssen Biotech, INC. | $234.43 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $143.83 | 2019 | |
| Janssen Products, LP | $99.99 | 2019 | |
| Merck Sharp & Dohme LLC | $82.93 | 2019 | |
| Glaxosmithkline, LLC. | $69.43 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $65.12 | 2019 | |
| Astellas Pharma US INC | $61.27 | 2019-2021 | |
| Mylan Institutional INC. | $43.92 | 2019 | |
| Napo Pharmaceuticals INC | $36.85 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $35.25 | 2019 | |
| Abbvie INC. | $29.99 | 2019-2021 | |
| Novo Nordisk INC | $27.91 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $25.96 | 2019 | |
| Lilly USA, LLC | $20.45 | 2019 | |
| Emd Serono, INC. | $19.98 | 2021 | |
| Amarin Pharma, INC. | $16.05 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $15.23 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.71 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $11.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Otha Myles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.